Format

Send to

Choose Destination
Biochem Biophys Res Commun. 2012 Sep 21;426(2):177-82. doi: 10.1016/j.bbrc.2012.08.052. Epub 2012 Aug 17.

Inhibition of tumor cell growth by Sigma1 ligand mediated translational repression.

Author information

1
Department of Pharmacology and Physiology, Drexel University College of Medicine, Philadelphia, PA 19102-1192, USA. fkim@drexelmed.edu

Abstract

Treatment with sigma1 receptor (Sigma1) ligands can inhibit cell proliferation in vitro and tumor growth in vivo. However, the cellular pathways engaged in response to Sigma1 ligand treatment that contribute to these outcomes remain largely undefined. Here, we show that treatment with putative antagonists of Sigma1 decreases cell mass. This effect corresponds with repressed cap-dependent translation initiation in multiple breast and prostate cancer cell lines. Sigma1 antagonist treatment suppresses phosphorylation of translational regulator proteins p70S6K, S6, and 4E-BP1. RNAi-mediated knockdown of Sigma1 also results in translational repression, consistent with the effects of antagonist treatment. Sigma1 antagonist mediated translational repression and decreased cell size are both reversible. Together, these data reveal a role for Sigma1 in tumor cell protein synthesis, and demonstrate that small molecule Sigma1 ligands can be used as modulators of protein translation.

PMID:
22925888
PMCID:
PMC3480203
DOI:
10.1016/j.bbrc.2012.08.052
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center